Jump Financial’s Tyra Biosciences TYRA Stock Holding History

Jump Financial’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Buy	+41,375	New	+$1.34M	0.02%	751
2025 Q4	–	Sell	-62,000	Closed	-$867K	–	2308
2025 Q3	$867K	Sell	62,000 -9,119	-13%	-$104K	0.01%	1073
2025 Q2	$681K	Buy	71,119 +43,170	+154%	+$410K	0.01%	1121
2025 Q1	$260K	Buy	27,949 +12,789	+84%	+$165K	﹤0.01%	1342
2024 Q4	$211K	Buy	+15,160	New	+$275K	﹤0.01%	1464
2024 Q3	–	Sell	-12,754	Closed	-$204K	–	2135
2024 Q2	$204K	Sell	12,754 -2,405	-16%	-$41.4K	﹤0.01%	1558
2024 Q1	$249K	Buy	+15,159	New	+$249K	0.01%	1547

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Jump Financial's TYRA Position: Q1 2026 in Review

Jump Financial opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 41,375 shares worth $1.58M. The stake represents 0.02% of the portfolio and ranks #751 among its holdings. This is a return to the name: Jump Financial previously reported a position in TYRA as recently as Q3 2025.

Jump Financial first reported a position in TYRA in Q1 2024 and has held it in 7 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

Jump Financial held 41,375 shares of Tyra Biosciences worth $1.58M as of Q1 2026.
Tyra Biosciences was a new Jump Financial position in Q1 2026.
Tyra Biosciences made up 0.02% of Jump Financial's portfolio in Q1 2026, its #751 holding.
Jump Financial first reported a position in Tyra Biosciences in Q1 2024 and has held it in 7 quarters since.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.